Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV005126043 | SCV005755611 | pathogenic | Multiple endocrine neoplasia, type 2 | 2024-05-05 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr905*) in the RET gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RET are known to be pathogenic (PMID: 22174939, 22648184). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with RET-related conditions. For these reasons, this variant has been classified as Pathogenic. |